In contrast, preclinical evidence suggests that higher amounts of BDNF and TrkB proteins were detected in the thoracolumbar spinal cord of IBS-like rats compared to control rats, and the administration of a selective TrkB antagonist reduced their visceral hypersensitivity [81]. Here, NTRK2 is linked to irritable bowel syndrome.